Advanced Search

 

Study ID Status Title Patient Level Data
114005 Completed A Phase 1, Open Label, Single Sequence, Three Period Study to Evaluate the Single Dose Pharmacokinetics of GSK1349572 100mg versus 50mg and the Effect of Efavirenz 600mg Once Daily on the Pharmacokinetics, Safety and Tolerability of GSK1349572 50mg Once Daily in Healthy Adult Subjects (ING114005)
114009 Completed A Phase I study to evaluate single and multiple (seven) oral doses of SRT2104 on the endotoxin induced inflammatory response in healthy male subjects Study Listed on ClinicalStudyDataRequest.com
114010 Completed A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
114011 Completed A Phase I Randomized, Placebo-Controlled, Single-Blind, Multiple-Dose, Dose-Escalation Clinical Study to Assess the Safety and Pharmacokinetics of SRT2379 in Normal Healthy Male Volunteers Study Listed on ClinicalStudyDataRequest.com
114012 Completed A Study to Evaluate Efficacy and Safety of Pazopanib Monotherapy in Asian women who have not progressed after first-line chemotherapy for advanced ovarian, fallopian tube or primary peritoneal carcinoma – An extension study to VEG110655
114013 Completed Systematic review of the clinical and cost effectiveness of treatments for idiopathic (immune) thrombocytopenic purpura (ITP): direct meta analysis
114014 Completed Indirect Comparison of efficacy of treatments for idiopathic immune thrombocytopenic purpura - review of platelet responses and bleeding events
114015 Completed Meta-analysis of efficacy of Topotecan and other treatments for recurrent carcinoma of the cervix
114016 Completed Indirect Comparison of the efficacy between topotecan and other treatments for recurrent carcinoma of the cervix
114021 Completed A Study of Biomarker Profiles in Asia Pacific erbB2+/HER2 Breast Cancer Patients Treated with Lapatinib and Other Anti-erbB2/HER2 Therapy
114025 Completed A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Parallel-Group Study to Compare the Efficacy, Tolerability, and Safety of 3 Doses of Gabapentin Enacarbil (GSK1838262) With Placebo in the Treatment of Subjects With Moderate-to-Severe Primary Restless Legs Syndrome (RLS)
114035 Completed Relative bioavailability study between the formulations: Paroxetine 25 mg tablets with controlled release manufactured by GSK Mississauga and Paroxetine 25 mg tablets with controlled release manufactured by SmithKline Beecham (Cidra), fed administration in healthy volunteers of both genders
114040 Completed Assessment of relative bioavailability of Avandamet 4 mg + 1000 mg (GSK) in the form of film coated tablets versus Avandamet 2 mg + 500 mg (GSK) in the form of film coated tablets, in healthy volunteers after feeding standardized, using Liquid Chromatography.
114041 Completed A Microdose Study to Describe the Intravenous Pharmacokinetics of [14C]-GSK2239633 in Healthy Male Subjects Study Listed on ClinicalStudyDataRequest.com
114043 Active, Not Recruiting Systematic Review and Meta-Analysis of the Impact of Alternative Treatments on Mortality Outcomes in Chronic Obstructive Pulmonary Disease (COPD)
114044 Completed A phase III, randomized, double blind, placebo-controlled clinical study to assess the efficacy and safety of GSK2402968 in subjects with Duchenne muscular dystrophy
114045 Completed Collection of Patients' Background InformationRelenza® Sentinel Site Monitoring Program in Japan
114056 Completed Immunogenicity, safety and reactogenicity of GSK Biologicals’ pneumococcal vaccine 1024850A when administered to children between 8 weeks and 2 years of age Study Listed on ClinicalStudyDataRequest.com
114061 Completed Observational, ecological, database study on epidemiology of hospitalisations with rotavirus gastroenteritis confirmed in children aged 5 years or less, and any impact in the change from lyophilised to liquid formulation of Rotarix™, in Belgium
114068 Completed A Single-centre, Randomised, Double-blind, Placebo-controlled, Escalating Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2256294 in Healthy Volunteers, and Single and Repeat Doses of GSK2256294 in Adult Male Moderately Obese Smokers Study Listed on ClinicalStudyDataRequest.com
114070 Completed A single-blind, placebo-controlled, two part study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of GSK2018682 in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
114071 Completed Randomized, two-period, cross-over, bioequivalence study on tamsulosin hydrochloride 0,4 mg prolonged release hard gelatin capsule versus SECOTEX® (tamsulosin hydrochloride) 0,4 mg prolonged release hard gelatin capsule (Boehringer Ingelheim) in healthy male volunteers under fasting conditions.
114073 Completed Randomized, two-period, cross-over, bioequivalence study on tamsulosin hydrochloride 0,4 mg prolonged release hard gelatin capsule versus SECOTEX® (tamsulosin hydrochloride) 0,4 mg prolonged release hard gelatin capsule healthy male volunteers under fed conditions
114078 Completed A multicenter, randomized, double-blind, parallel-group, placebo-controlled study including an open-label phase to evaluate the efficacy and safety of GSK1358820 (botulinum toxin type A) in patients with axillary hyperhidrosis
114083 Completed Long-term follow-up of participants from studies evaluating the HIV vaccine 732462

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.